Request Deal Involvement
Life Sciences at Goldman Sachs Alternatives led a $75m Series C round in Beacon Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
ICR Healthcare
legal advisors
Latham & Watkins
or
Principals
target
BEACON THERAPEUTICS LIMITED
bidder
FORBION CAPITAL PARTNERS
bidder
GOLDMAN SACHS ALTERNATIVES
bidder
SYNCONA LTD
bidder
OXFORD SCIENCE ENTERPRISES
bidder
ADVENT LIFE SCIENCES
bidder
RETINAL DEGENERATION FUND
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2026 Datasite